IDiyas

For the Inventor, By the Inventor

Copenhagen, Denmark

Leif H Jensen

USPTO Granted Patents = 23

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 159(Granted Patents)


Location History:

  • Hellerup, DK (1986 - 1988)
  • Copenhagen, DK (1989 - 1999)

Company Filing History:

goldMedal12 out of 206 
 
Neurosearch A/s
 patents
silverMedal7 out of 41 
 
A/s Ferrosan
 patents
bronzeMedal4 out of 1,384 
 
Schering Aktiengesellschaft
 patents

Years Active: 1986-1999

Loading Chart...
23 patents (USPTO):Explore Patents
1. 5998405 - Fused tropane-derivatives as neurotransmitter reuptake inhibitors (1999-12-07),
2. 5554626 - Substituted heterocyclic compounds as dopamine-reuptake inhibitors (1996-09-10),
3. 5478859 - Indole-derivatives, method of treatment therewith, and pharmaceutical (1995-12-26),
4. 5475015 - Benzimidazole derivatives, their preparation and pharmaceutical use (1995-12-12),
5. 5444070 - Phenyl substituted heterocyclic compounds (1995-08-22),
6. 5374636 - 2,3-trans-disubstituted tropane compounds which have useful (1994-12-20),
7. 5369113 - Certain 2,3-diphenyl-2-(1,2,4-oxadiazol-5-yl)tropanes useful as dopamide (1994-11-29),
8. 5270306 - Method of antagonizing excitatory amino acids by administration of (1993-12-14),
9. 5242918 - Isatinoxime derivatives, their preparation and use (1993-09-07),
10. 5223527 - Isatineoxime derivatives and their use (1993-06-29),
11. 5198461 - Isatine derivatives, their preparation and use (1993-03-30),
12. 5158969 - Indole derivatives as potassium channel blockers (1992-10-27),
13. 4933353 - Lipophilically-substituted piperidine oxadiazolyl compounds and their (1990-06-12),
14. 4837241 - Lipophillically-substituted piperidine oxadiazolyl compounds and their (1989-06-06),
15. 4778800 - 3-oxadiazole and 3-carboxylic acid beta-carboline derivatives, and their (1988-10-18),

Title: Leif H Jensen: Innovator in Neuropharmacology

Introduction

Leif H Jensen is a renowned inventor based in Copenhagen, Denmark, with a remarkable portfolio of 23 patents. His work primarily focuses on neuropharmacological innovations, particularly in the realm of neurotransmitter reuptake inhibitors. Jensen's contributions have significantly advanced the understanding and treatment of various neurological disorders.

Latest Patents

Among his latest patents, notable inventions include:

1. **Fused tropane-derivatives as neurotransmitter reuptake inhibitors** – This patent addresses the development of novel compounds aimed at enhancing neurotransmitter regulation.

2. **Substituted heterocyclic compounds as dopamine-reuptake inhibitors** – This invention discloses compounds with pharmaceutical applications, particularly those that possess valuable properties as dopamine reuptake inhibitors. The compounds include a complex formula where various variables are defined for specific applications in pharmacology.

Career Highlights

Leif H Jensen has had a fruitful career, collaborating with prominent companies such as Neurosearch A/S and Ferrosan A/S. His expertise in neuropharmacology has positioned him as a leading figure in the development of therapeutic strategies for neurological conditions, influencing the pharmaceutical industry significantly.

Collaborations

Throughout his career, Jensen has worked alongside distinguished colleagues, including Frank Watjen and Peter Moldt. These collaborations have not only enriched his research but also fostered innovation in their shared field of interest.

Conclusion

Leif H Jensen's contributions to the field of neuropharmacology through his patents exemplify the importance of innovation in medicine. His ongoing research continues to inspire future advancements in the treatment of neurological disorders, making a lasting impact on health care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…